BRAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for BRAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRCA1 Human Pre-designed siRNA Set A contains three designed siRNAs for BRCA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRCA2 Human Pre-designed siRNA Set A contains three designed siRNAs for BRCA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRCC3 Human Pre-designed siRNA Set A contains three designed siRNAs for BRCC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRD-SF2 is a BRD4-targeted PROTAC degrader (DC50: 17.2 μM) (Blue: VHL ligand, black: linker, pink: BRD4 ligand)[1].

BRD1 Human Pre-designed siRNA Set A contains three designed siRNAs for BRD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRD1401 is a small molecule targeting the outer membrane protein OprH. BRD1401 disrupts the interaction of OprH with LPS. BRD1401 can increase membrane fluidity[1].

BRD2 Human Pre-designed siRNA Set A contains three designed siRNAs for BRD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brd2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Brd2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRD2 Rat Pre-designed siRNA Set A contains three designed siRNAs for BRD2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRD3 Human Pre-designed siRNA Set A contains three designed siRNAs for BRD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brd3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Brd3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brd3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Brd3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRD4 Human Pre-designed siRNA Set A contains three designed siRNAs for BRD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRD4 inhibitor-30 (Compound 1) is a BRD4 inhibitor with a IC50 value of 415 nM[1].

BRD4 inhibitor-30 (Compound 1) is a BRD4 inhibitor with a IC50 value of 415 nM[1].

BRD4 Inhibitor-31 (Example 136) is a BRD4 inhibitor (Kis: 0.234 μM and 0.295 μM for BRD4 BD1 and BRD4 BD2 respectively). BRD4 Inhibitor-31 can be used for research of inflammatory diseases, cancer, and AIDS[1].

BRD4 Inhibitor-32 (example 15) is a BRD4 inhibitor that can be used in acute kidney disease and chronic kidney disease research[1].

BRD4 Inhibitor-33 (example 13) is a BRD4 inhibitor that can be used in acute kidney disease and chronic kidney disease research[1].

BRD4 Inhibitor-34 (Compound 12a) is a BRD4 inhibitor with an IC50 of 24 μM[1].

Brd4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Brd4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brd4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Brd4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRD4-BD1-IN-3 (Compound 4g) is a BRD4-BD1 inhibitor. BRD4-BD1-IN-3 can be used for research of inflammatory disease[1].

BRD4-IN-5 (example 51) is a BRD4 inhibitor. The Ki values of the two BRD4 domains BDI_K57-E168 and BDII_E352-M457 are 9.7 nM and 16.1 nM, respectively. BRD4-IN-5 can be used in cancer research[1].

BRD4-IN-6 (compound 116) is a BRD4 inhibitor (extracted from patent CN107721975A).

BRD4-IN-7 (compound 120) is a BRD4 inhibitor(extracted from patent CN107721975A).

BRD4-IN-8 (Example 13b) is a BRD4 inhibitor[1].

BRD4/NAMPT-IN-1 (Compound A2) shows strong inhibitory effects on NAMPT and BRD4 (IC50=35 nM (NAMPT) and 58 nM (BRD4)). BRD4/NAMPT-IN-1 inhibits the growth and migration of hepatocellular carcinoma cells and promotes apoptosis. BRD4/NAMPT-IN-1 also shows potent anticancer effects in HCCLM3 xenograft mouse model, with no obvious toxic effects[1].

BRD7 Human Pre-designed siRNA Set A contains three designed siRNAs for BRD7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brd7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Brd7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brd7 Rat Pre-designed siRNA Set A contains three designed siRNAs for Brd7 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRD8 Human Pre-designed siRNA Set A contains three designed siRNAs for BRD8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRD9 Human Pre-designed siRNA Set A contains three designed siRNAs for BRD9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brd9 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Brd9 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brd9 Rat Pre-designed siRNA Set A contains three designed siRNAs for Brd9 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRDT Human Pre-designed siRNA Set A contains three designed siRNAs for BRDT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brdt Mouse Pre-designed siRNA Set A contains three designed siRNAs for Brdt gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brdt Rat Pre-designed siRNA Set A contains three designed siRNAs for Brdt gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brevicidine analog 22 (22) exerts broad spectrum antimicrobial activity and excellent stability (t1/2 = 40.98 h), with MICs of 2-16 μM for gram-negative and gram-positive bacteria[1].

BRF1 Human Pre-designed siRNA Set A contains three designed siRNAs for BRF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRF2 Human Pre-designed siRNA Set A contains three designed siRNAs for BRF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRI3 Human Pre-designed siRNA Set A contains three designed siRNAs for BRI3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRI3BP Human Pre-designed siRNA Set A contains three designed siRNAs for BRI3BP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRINP1 Human Pre-designed siRNA Set A contains three designed siRNAs for BRINP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRINP2 Human Pre-designed siRNA Set A contains three designed siRNAs for BRINP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BRINP3 Human Pre-designed siRNA Set A contains three designed siRNAs for BRINP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Brinzolamide (Standard) is the analytical standard of Brinzolamide. This product is intended for research and analytical applications. Brinzolamide (AL-4862) is a selective carbonic anhydrase II inhibitor with anIC50 value of 3.2 nM. Brinzolamide hydrochloride reduces intraocular pressure (IOP) by inhibiting ciliary CA-II and decreasing atrial fluid secretion. Brinzolamide can be used in glaucoma disease research[1][2].

BRIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for BRIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BrIR2 is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes are also widely […]